A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) death rate and recurrence rate have remained obstinately high. Current methods can not satisfy the need of predicting cancer relapse accurately. Utilizing expression profiles of 10 GEO datasets (N = 774), we identified 154 differentially expressed genes (DEGs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Guodong, Zhang, Jingjing, Lu, Zipeng, Liu, Dongfang, Wu, Yang, Wu, Pengfei, Yin, Jie, Yuan, Hao, Zhu, Qicong, Chen, Lei, Fu, Yue, Peng, Yunpeng, Wang, Yan, Jiang, Kuirong, Miao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762289/
https://www.ncbi.nlm.nih.gov/pubmed/29340021
http://dx.doi.org/10.18632/oncotarget.22861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762289/
https://www.ncbi.nlm.nih.gov/pubmed/29340021
http://dx.doi.org/10.18632/oncotarget.22861

Ejemplares similares